2-(Furan-2-yl)-6-nitroquinoline-4-carboxylic acid, 95%, 250mg

3-[4-(trifluoromethyl)phenyl]-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 2g

2-(Chloromethyl)benzonitrile, 98.0%, 10g

H-Glu(OtBu)-Ome.HCl, 95%, 10g

Cuba de muestra Tipo 2116, 60 ml, 4 Unidad(es)

(4-(Cyanomethyl)phenyl)boronic acid, 95.0%, 25g

3-Bromoisoquinoline, 95.0%, 1g

1,3 DIBROMOBUTANE, >98.0%(GC), 500g

3-Bromo-4-fluoro-benzenesulfonamide, 95.0%, 1g

2-Ethoxy-4-methylbenzaldehyde, 95%, 5g

1-[1H-1,2,3-Benzotriazol-1-yl(phenyl)methyl]-1H-1,2,3-benzotriazole, 250mg

4-(2,5-Dioxotetrahydrofuran-3-yl)-1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic Anhydride>97.0%(HPLC)(T)5g

Ethyl 5-Bromo-1H-pyrrolo-[2,3-c]-pyridine-2-carboxylate, 95.0%, 250mg